<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two types of mutations of a transcription factor CCAAT-enhancer binding protein α (C/EBPα) are found in leukemic cells of 5%-14% of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) patients: N-terminal mutations expressing dominant negative p30 and C-terminal mutations in the basic leucine zipper domain </plain></SENT>
<SENT sid="1" pm="."><plain>Our results showed that a mutation of C/EBPα in one allele was observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> after <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, while the 2 alleles are mutated in de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Unlike an N-terminal frame-shift mutant (C/EBPα-N(m))-transduced cells, a C-terminal mutant (C/EBPα-C(m))-transduced cells alone induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with <z:hpo ids='HP_0001882'>leukopenia</z:hpo> in mice 4-12 months after bone marrow transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>Coexpression of both mutants induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with marked <z:hpo ids='HP_0001974'>leukocytosis</z:hpo> with shorter latencies </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, C/EBPα-C(m) collaborated with an Flt3-activating mutant Flt3-ITD in inducing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, C/EBPα-C(m) strongly blocked myeloid differentiation of 32Dcl3 cells, suggesting its class II mutation-like role in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Although C/EBPα-C(m) failed to inhibit transcriptional activity of <z:mp ids='MP_0002169'>wild-type</z:mp> C/EBPα, it suppressed the synergistic effect between C/EBPα and PU.1 </plain></SENT>
<SENT sid="7" pm="."><plain>On the other hand, C/EBPα-N(m) inhibited C/EBPα activation in the absence of PU.1, despite low expression levels of p30 protein generated by C/EBPα-N(m) </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, 2 types of C/EBPα mutations are implicated in leukemo-genesis, involving different and cooperating molecular mechanisms </plain></SENT>
</text></document>